CUORIPS, INC.
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.
CUORIPS, INC.
Industry:
Health Care Medical Medical Device
Founded:
2017-03-21
Address:
Chuo, Hokkaido, Japan
Country:
Japan
Website Url:
http://www.cuorips.co.jp
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
43.85 M USD
Technology used in webpage:
SPF Euro Google Apps For Business SAKURA Internet GMO Internet DNS
Similar Organizations
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Current Employees Featured
Founder
Investors List
Nippon Venture Capital
Nippon Venture Capital investment in Venture Round - Cuorips, Inc.
Hashidzume Katsuya
Hashidzume Katsuya investment in Venture Round - Cuorips, Inc.
Fujifilm
Fujifilm investment in Venture Round - Cuorips, Inc.
CellSource
CellSource investment in Venture Round - Cuorips, Inc.
JIC Venture Growth Investments
JIC Venture Growth Investments investment in Venture Round - Cuorips, Inc.
Asahi Intecc
Asahi Intecc investment in Venture Round - Cuorips, Inc.
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Venture Round - Cuorips, Inc.
Terumo Corporation
Terumo Corporation investment in Venture Round - Cuorips, Inc.
Dai-Dan
Dai-Dan investment in Venture Round - Cuorips, Inc.
StemCell Institute
StemCell Institute investment in Venture Round - Cuorips, Inc.
Official Site Inspections
http://www.cuorips.co.jp
- Host name: www646b.sakura.ne.jp
- IP address: 112.78.125.106
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Cuorips, Inc."
Cuorips Inc.
Nov 23, 2014 JP; EN; Moving people’s hearts and maintaining their lives. News Topics. 24/12/17 ... Announcement of Presentation at AHA (American Heart Association) Scientific Session. …See details»
Corporate Profile - Cuorips Inc.
Cuorips Inc. Location Head office (registered address) ⇒MAP 507, Nihonbashi Life Science Building 2, 3-11-5 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023 Osaka Laboratory ⇒MAP …See details»
Cuorips Inc, 4894:TYO profile - FT.com - Financial Times
3 days ago Cuorips Inc (4894:TYO) company profile with history, revenue, mergers & acquisitions, ... in the development and commercialization of regenerative medical products …See details»
Cuorips - Crunchbase Company Profile & Funding
Organization. Cuorips . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; CUORiPS is …See details»
Philosophy | Cuorips Inc.
“Cuorips” is a combination of “Cuore,” an Italian word meaning “the heart,” and “iPS,” which stands for “induced pluripotent stem” cells. Our Philosophy Cuorips is a company that …See details»
Cuorips Inc. (TYO: 4894) Company Profile & Overview - Stock …
Nov 21, 2024 Cuorips Company Description Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The …See details»
Company Cuorips Inc. - MarketScreener.com
Jul 31, 2020 Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and …See details»
Cuorips Inc. (4894.T) Company Profile & Facts - Yahoo Finance
81 3 6231 0043 https://cuorips.co.jp . Sector: ... Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan. Corporate Governance .See details»
INVESTOR RELATIONS - Cuorips Inc.
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan. TOP; NEWS; ABOUT US. Corporate Profile; Company History; …See details»
Startup to Apply For Approval to Produce Heart Cell Sheets from …
May 28, 2024 Tokyo-based Cuorips Inc. will apply with the Health, Labor and Welfare Ministry as early as June for permission to produce and sell the sheets, which are to be transplanted into …See details»
Cuorips Inc, 4894:TYO summary - FT.com - Financial Times
Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and …See details»
Cuorips Company Profile 2024: Stock Performance & Earnings
Cuorips has 62 total employees. What industry is Cuorips in? Cuorips’s primary industry is Drug Discovery. Is Cuorips a private or public company? Cuorips is a Public company. What is …See details»
Company History - Cuorips Inc.
Changed the company name to Cuorips Inc. August 2017: Concluded a contract for stock underwriting with Daiichi Sankyo Co., Ltd: October 2017: Concluded a contract for joint …See details»
Cuorips (TSE:4894) - Stock Price, News & Analysis - Simply Wall St
Oct 31, 2024 Research Cuorips' (TSE:4894) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... cuorips.co.jp: …See details»
CUORiPS - Overview, News & Similar companies | ZoomInfo.com
Who is CUORiPS. CUORiPS Inc. is a start-up company, established in March 2017, based on technology and research results of Osaka University, for the development an d …See details»
スタンフォード大学心臓胸部外科のホームページに当社との共同 …
スタンフォード大学心臓胸部外科のホームページに当社との共同研究契約締結が掲載されました. 2024/12/23; new お知らせ; 2024/12/17のirニュースについて、追加のお知らせを掲載しており …See details»
Organization: Cuorips - Cbonds.com
Ratings from the top 3 global ratings agencies, plus over 70 local onesSee details»
Announcement of Joint Research Agreement with Stanford …
6 days ago CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan. TOP; NEWS; ABOUT US. ... Office（CLiC-1） Access; OUR …See details»
2024年 | Cuorips Inc.
NEWS. 2024年. 2024/12/17. NEW release. Announcement of Joint Research Agreement with Stanford University’s Department of Cardiothoracic SurgerySee details»
NEWS | Cuorips Inc.
JP; EN; NEWS. NEWS. 2024/12/17. NEW release. Announcement of Joint Research Agreement with Stanford University’s Department of Cardiothoracic Surgery. 2023/11/15. release. ...See details»